US 12,139,488 B2
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
Pierre Louis Beaulieu, Rosemère (CA); and Michael Dore, Saint-Bruno-de-Montarville (CA)
Assigned to Université de Montréal, Montréal (CA)
Filed by Universite de Montreal, Montreal (CA)
Filed on Apr. 5, 2024, as Appl. No. 18/628,424.
Application 18/628,424 is a continuation of application No. 18/386,433, filed on Nov. 2, 2023.
Application 18/386,433 is a continuation of application No. 18/287,610, previously published as PCT/CA2022/050592, filed on Apr. 19, 2022.
Claims priority of provisional application 63/201,219, filed on Apr. 19, 2021.
Prior Publication US 2024/0317747 A1, Sep. 26, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 471/04 (2006.01); A61P 35/00 (2006.01); C07D 519/00 (2006.01)
CPC C07D 471/04 (2013.01) [A61P 35/00 (2018.01); C07D 519/00 (2013.01)] 22 Claims
 
1. A compound of formula:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof, wherein:

OG Complex Work Unit Chemistry